Prevalence of pain and treatment outcomes among cancer patients in a Malaysian palliative care unit
| Autor: | Morna Chua, Jerry Liew, Ilmiyah Che Wan, Jacqueline Lai, Syuhaidah Abdul Rahman, Thamron Keowmani, Melissa Mejin |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Palliative care
Treatment outcome lcsh:RS1-441 Pharmaceutical Science Pharmacy 030226 pharmacology & pharmacy Analgesics Non-Narcotic 0302 clinical medicine mesh:Pain Prevalence Medicine mesh:Analgesics mesh:Patient Reported Outcome Measures Original Research Pain Measurement mesh:Palliative Care Terminal Care Analgesics Palliative Care Treatment Outcome mesh:Treatment Outcome medicine.drug medicine.medical_specialty mesh:Terminal Care Analgesic Pain Opioid mesh:Pain Measurement lcsh:Pharmacy and materia medica 03 medical and health sciences Rating scale Internal medicine mesh:Pain Management Non-Narcotic Pain Management mesh:Opioid Patient Reported Outcome Measures mesh:Malaysia business.industry lcsh:RM1-950 Malaysia Cancer Pain management medicine.disease lcsh:Therapeutics. Pharmacology mesh:Non-Narcotic Analgesics Opioid business Patient education |
| Zdroj: | Pharmacy Practice (Granada), Volume: 17, Issue: 1, Article number: 1397, Published: 11 NOV 2019 Pharmacy Practice, Vol 17, Iss 1, p 1397 (2019) Pharmacy Practice (Granada) v.17 n.1 2019 SciELO España. Revistas Científicas Españolas de Ciencias de la Salud instname Pharmacy Practice |
| ISSN: | 1886-3655 1885-642X |
| DOI: | 10.18549/pharmpract.2019.1.1397 |
| Popis: | Background: Pain remains one of the most common and debilitating symptoms of advanced cancer. To date, there is a lack of studies on pain and its treatment among Malaysian palliative care patients. Objective: This study aimed to explore the prevalence of pain and its treatment outcomes among adult cancer patients admitted to a palliative care unit in Sabah, Malaysia. Methods: Of 327 patients screened (01/09/15-31/12/17), 151 patients with assessed self-reported pain scores based on the numerical rating scale of 0-10 (current, worst and least pain within the past 24 hours) upon admission (baseline), 24, 48 and 72 hours post-admission and discharge were included. Pain severity and pain score reductions were analysed among those who experienced pain upon admission or in the past 24 hours. Treatment adequacy was measured by the Pain Management Index (PMI) among discharged patients. The PMI was constructed upon worst scores categorised as 0 (no pain), 1 (1-4, mild pain), 2 (5-6, moderate pain), or 3 (7-10, severe pain) which is then subtracted from the most potent level of prescribed analgesic drug scored as 0 (no analgesia), 1 (non-opioid), 2 (weak opioid) or 3 (strong opioid). PMI≥0 indicated adequate treatment. Results: Upon admission, 61.1% [95%CI 0.54:0.69] of 151 patients presented with pain. Of 123 patients who experienced pain upon admission or in the past 24 hours, 82.1% had moderate to severe worst pain. Throughout patients’ ward stay until discharge, there was an increased prescribing of analgesics and adjuvants compared to baseline, excluding weak opioids, with strong opioids as the mainstay treatment. For all pain score types (current, worst and least pain within the past 24 hours), means decreased at each time point (24, 48 and 72 hours post-admission and discharge) from baseline, with a significant decrease at 24 hours post-admission (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|